CO-FOUNDERS

IMG_0046-TN.jpg

TOMMY NGUYEN, M.D. PH.D.

Co-founder, CEO

ANDREW KOFF, PH.D.

Co-founder, CSO

AK pic.jpg
 

ADVISORS

JAN VIJG, PH.D.

Albert Einstein College of Medicine, Chair and Professor, Department of Genetics; Renowned geneticist and expert researcher in the field of chromatin and aging

JOHN SEDIVY, PH.D.

Brown University, Professor, Department of Molecular Biology, Cell Biology, and Biochemistry; Renowned expert researcher in the field of senescence and its role in aging

WILLIAM (BILL) TAP, M.D.

Memorial Sloan-Kettering Cancer Center, Clinical section Chief of Sarcoma; Oncologist and expert in leading clinical trials for rare diseases

JOHN PETRINI, PH.D.

Memorial Sloan-Kettering Cancer Center, Chair and Professor, Department of Molecular Biology; Mouse modeling expert researcher in the field of chromatin, DNA damage, and senescence

OLIVER STAUCH, PH.D.

Ascendis Pharma (ticker ASND), Vice-President; Biotechnology and Pharma executive (previous roles at Roche/Chugai) who has coordinated development of ophthalmic, antibody, and intravenous drugs

TERESA (TERRY) CALARCO

Lawrence Livermore Berkeley Labs, Senior Manager, Materials Sciences Division; Business Operations and Laboratory Support executive

 

©2018 by Atropos Therapeutics Inc.. Proudly created with Wix.com